This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a ceiling value of $3,324.97 and an ultimate completion date of November 7, 2024. It is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation.
The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical and medical products to support U.S. Armed Forces medical operations. The company has been awarded numerous delivery orders under this IDC for a wide spectrum of medical products, positioning it as a key strategic supplier for the DLA's medical supply chain needs.
Generated 2/5/25, 9:36 AM